Molecular Insights in Hepatic Disease and Hepatocellular Carcinoma
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 82
Special Issue Editors
Interests: hepatic diseases and hepatocellular carcinoma
Special Issue Information
Dear Colleagues,
The field of hepatology has witnessed remarkable research and revolutionary developments in recent years. Particularly in the treatment of advanced hepatocellular carcinoma (HCC), the widespread use of immune checkpoint inhibitors presents the potential to extend treatment efficacy to early and intermediate stages of HCC. In the field of viral hepatitis, significant progress has been marked by the use of high-potency nucleos(t)ide analogues. Additionally, several clinical trials are implementing new drug combinations aimed at achieving an HBV cure. Additionally, in the realm of fatty liver disease, a new term—metabolic dysfunction-associated steatotic liver disease—has been introduced, with numerous promising drugs currently undergoing clinical trials.
In alignment with these revolutionary strides, this Special Issue aims to provide an overview of molecular insights in hepatic diseases and hepatocellular carcinoma. It will encompass various basic and translational research related to a spectrum of hepatic disorders. We therefore invite you to submit research papers to this Special Issue.
Potential topics include, but are not limited to:
- Hepatology;
- Viral hepatitis;
- Metabolic dysfunction-associated steatotic liver disease;
- Alcohol-associated liver disease;
- Liver cirrhosis;
- Hepatocellular carcinoma;
- Liver transplantation;
- Mechanisms of action;
- Molecular research;
- Antivirals;
- Molecular targeting therapy;
- Immune checkpoint inhibitor.
Dr. Soon Kyu Lee
Dr. Jong-Young Choi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatology
- viral hepatitis
- liver cirrhosis
- hepatocellular carcinoma
- liver transplantation
